Lithium ions: A novel treatment for pheochromocytomas and paragangliomas
- 1 February 2007
- Vol. 141 (2) , 161-165
- https://doi.org/10.1016/j.surg.2006.12.005
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cellsMolecular Cancer Therapeutics, 2005
- Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factorsAmerican Journal of Physiology-Renal Physiology, 2005
- PheochromocytomaPublished by Elsevier ,2005
- Regulation of TRAIL Expression by the Phosphatidylinositol 3-Kinase/Akt/GSK-3 Pathway in Human Colon Cancer CellsJournal of Biological Chemistry, 2002
- Glycogen Synthase Kinase-3βCirculation Research, 2002
- The renaissance of GSK3Nature Reviews Molecular Cell Biology, 2001
- Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from deathJournal of Neurochemistry, 2001
- Adrenocorticotropic hormone-secreting pheochromocytomas: The exception to the ruleSurgery, 1995
- Lithium‐stimulated proliferation and alteration of phosphoinositide metabolites in MCF‐7 human breast cancer cellsJournal of Cellular Physiology, 1995
- Glycogen synthase kinase 3 regulates cell fate in dictyosteliumCell, 1995